Search Results - David Y. Mitchell
- Showing 1 - 1 results of 1
-
1
Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration‐QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers by Andreas Becker, Emily C. Martin, David Y. Mitchell, Roland Grenningloh, Andrew T. Bender, Julien Laurent, Harald Mackenzie, Andreas Johne
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book